In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EPIX Pharmaceuticals, Inc.

http://www.epixpharma.com/

Latest From EPIX Pharmaceuticals, Inc.

Poolbeg Pharma's Capital-Light Model For New Anti-Infectives Development

A new UK company, Poolbeg Pharma, has been set up to develop new anti-infectives in an efficient manner, and already has a repositioned MAP kinase inhibitor for the treatment of severe influenza ready for Phase II studies.

Infectious Diseases Financing

Finance Watch: US, Hong Kong IPOs Are Hot, But Sirnaomics Stays Private

Private Company Edition: Sirnaomics planned to go public after its series D, but its new venture capital does not prevent it from doing so in the near term. Also, Vida Ventures and Novalis Biotech raised new VC funds to back start-ups and ArriVent launched with up to $150m in series A cash.

Financing Innovation

CMS Announces Virtual Meetings To Discuss HCPCS Codes

The US Centers for Medicare & Medicaid Services (CMS) has announced the July schedule for its virtual Healthcare Common Procedure Coding System (HCPCS) public meetings.

Medicaid Medicare

Bausch Says B+L Spinout Or IPO Could Occur During ‘October Timeframe’

During Bausch Health’s first quarter earnings call, CEO Papa said he’ll lead Bausch + Lomb following the corporate split. Overall the company reported flat revenues, but said its pandemic rebound is ongoing.

Sales & Earnings Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Predix Pharmaceuticals Holdings, Inc.
UsernamePublicRestriction

Register